Cite
MLA Citation
X. Liu et al.. “THU0080 PRECLINICAL CHARACTERIZATION OF TLL018, A NOVEL, HIGHLY POTENT AND SELECTIVE JAK1/TYK2 INHIBITOR FOR TREATING AUTOIMMUNE DISEASES.” Annals of the rheumatic diseases, vol. 79, n.d., p. 252. http://access.bl.uk/ark:/81055/vdc_100144724633.0x000044